Anterior Uveitis Caused by Ocular Side Effects of Afatinib: A Case Report
Afatinib is a second-generation epidermal growth factor receptor (EGFR) inhibitor that has been shown to be effective against EGFR-mutated non-small cell lung cancer (NSCLC) resistant to conventional EGFR inhibitors such as gefitinib and erlotinib.Although ocular side effects of gefitinib and erlotinib have been reported, those for afatinib have ye